Carol Wrenn Joins Heska's Board of Directors

                 Carol Wrenn Joins Heska's Board of Directors

Animal Industry Veteran Augments Heska's Board of Directors

PR Newswire

LOVELAND, Colo., Jan. 4, 2013

LOVELAND, Colo., Jan. 4, 2013 /PRNewswire/ --Heska Corporation (NASDAQ: HSKA,
"Heska" or the "Company"), a leading provider of veterinary diagnostic and
specialty products, announced today that Carol Wrenn had joined Heska's Board
of Directors.

Ms. Wrenn is a founder and current President of Sky River Helicopters, LLC.
From 2001 to 2009, she was President of the Animal Health Division and an
Executive Vice President of Alpharma Inc. During her tenure at Alpharma, Ms.
Wrenn is credited for the turnaround and subsequent revenue and earnings
growth of the Animal Health business. Prior to joining Alpharma, Ms. Wrenn
held various executive positions at Honeywell International Inc. (formerly
Allied Signal Inc.) from 1984 to 2001.

Ms. Wrenn currently serves on the Board of Phibro Animal Health Corporation.
She chaired the Animal Health Institute from 2007 to 2009 and was a Board
member of the International Federation of Animal Health (IFAH) from 2002 to

"I am pleased to join the talented Board Heska has assembled," commented Ms.
Wrenn. "I am excited to assist Heska in its drive to offer veterinarians
state-of-the-art products and enhance shareholder value."

"We are delighted to add a new Board member with such strong animal health
credentials," said Robert Grieve, Heska's Chairman and Chief Executive
Officer. "Her proven background in driving growth and creating value will be
valuable to Heska and its shareholders as we continue to introduce new
products and leverage our improving sales organization. We are always
interested in pursuing new Board members who offer complementary skills and
are glad Ms. Wrenn has agreed to join us."

About Heska

Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and
other specialty veterinary products. Heska's state-of-the-art offerings to
its customers include diagnostic instruments and supplies as well as single
use, point-of-care tests, pharmaceuticals and vaccines. The Company's core
focus is on the canine and feline markets where it strives to provide high
value products and unparalleled customer support to veterinarians. For
further information on Heska and its products, visit the company's website at

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future
financial and operating results. These statements are based on current
expectations and are subject to a number of risks and uncertainties. There are
uncertainties regarding the ability of any Board member, or the Board of
Directors as a group, to impact Heska's operating and financial performance;
uncertainties related to Heska's ability to recruit new Board members;
uncertainties related to Heska's ability to retain its current Board members;
and the risks set forth in Heska's filings and future filings with the
Securities and Exchange Commission, including those set forth in Heska's
Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.

SOURCE Heska Corporation

Contact: At Heska Corporation, Jason Napolitano, Executive Vice President &
CFO, +1-970-493-7272, Ext. 4105; or At Hayden IR, Brett Maas, Managing
Partner, +1-646-536-7331,
Press spacebar to pause and continue. Press esc to stop.